136 results on '"Bourg, Véronique"'
Search Results
2. Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
3. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
4. Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
5. Maladies neuromusculaires
6. Amyoplasia and distal arthrogryposis
7. Complementary and alternative medicine use in glioma patients in France
8. Liste des auteurs
9. 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
10. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review
11. Hypoxemia following generalized convulsive seizures: Risk factors and effect of oxygen therapy
12. Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
13. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
14. Added value of 18F-FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
15. Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase
16. Diagnostic workup in children with arthrogryposis: description of practices from a single reference centre, comparison with literature and suggestion of recommendations.
17. Chapitre 5 - Maladies neuromusculaires
18. Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
19. Drooling Impact Questionnaire--French Version
20. Diagnostic workup in children with arthrogryposis: description of practices from a single reference centre, comparison with literature and suggestion of recommendations
21. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
22. Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
23. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
24. Faisabilité d’une étude radiomique en routine clinique dans une cohorte de patients traités pour un glioblastome présentant une nouvelle lésion rehaussée au cours du suivi IRM
25. Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis
26. Identifying a reliable radiomic signature from scarce data: illustration for 18F-FDOPA PET images in glioblastoma patients
27. Validity, reliability and responsiveness to change of the French version of the drooling impact scale.
28. Early Toxicities After High Dose Rate Proton Therapy in Cancer Treatments
29. Validity, reliability and responsiveness to change of the French version of the drooling impact scale
30. Analyse radiomique des gliomes de bas grades : une étude rétrospective
31. Effects of dual tasking on postural and gait performances in children with cerebral palsy and healthy children
32. Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer
33. Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
34. ANALYSIS OF GAIT DURING INDEPENDENT AND PAIRED WALKING IN ADULTS WITH AN INTELLECTUAL DISABILITY: A CASE REPORT
35. Bevacizumab: Is the lower the better for glioblastoma patients in progression?
36. Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.
37. Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis
38. Quels sont les marqueurs biologiques de suivi disponibles pour le suivi d’un traitement par rituximab dans la myasthénie généralisée ?
39. Suivi peri-opératoire et longitudinal de la mémoire de travail dans les gliomes de bas grade
40. Suivi des lymphocytes B mémoires CD27+ : marqueur biologique de rechute permettant de déterminer la fréquence des perfusions du Rituximab dans la myasthénie généralisée
41. Characteristics of H3 K27M-mutant gliomas in adults
42. Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase
43. Pediatric rehabilitation and pediatric oncology: A winner association: The experience of Grenoble pediatric hospital
44. Is visual feedback pertinent for gait rehabilitation? Preliminary study of plantar pressure control with visual feedback in healthy people
45. 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
46. Le suivi des sous-populations des lymphocytes B par cytométrie de flux conditionne l’administration du Rituximab (RTX) dans la myasthénie généralisée (MG)
47. Traumatismes de l’épaule liés aux crises d’épilepsie
48. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients
49. Complex partial status epilepticus revealing anti-NMDA receptor encephalitis
50. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.